107results about How to "High therapeutic effect" patented technology

Oligonucleotides having a nucleotide sequence complementary to nucleotide numbers such as 2571-2607, 2578-2592, 2571-2592, 2573-2592, 2578-2596, 2578-2601 or 2575-2592 of the dystrophin cDNA (Gene Bank accession No. NM_004006.1) and therapeutic agents for muscular dystrophy comprising such oligonucleotides.

Technical Field: TeaTechnical Problem: To provide a drinkable tea having a high therapeutic effect against atopic dermatitis.Means for Solving: It is characterized in that it contains extracts drawn from one, two or more medicinal herbs selected from the group consisting of Lightyellow Sophora Root, Isatis Leaf, and Terminalia Fruit. Atopic dermatitis can be cured by improving allergic constitution from the inside of body owing to antibacterial effect and antiviral effect of Lightyellow Sophora Root, Isatis Leaf and Terminalia Fruit, antiallergic effect of Lightyellow Sophora Root and Isatis Leaf, and intestinal mucosal protecting effect of Terminalia Fruit, or by a synergistic effect of them.In addition, the pharmacological effect in said extracts drawn from plants is enhanced, a pharmacological effects lacking in said extracts drawn from plants are added, or easiness of drinking the tea as a drinkable drug is improved and thus the therapeutic effect is improved by adding one, two or more auxiliary materials selected from the group of Japanese Angelica Root, Oldenlandia diffusa, Smilax Glarba, Dried Tangerine Peel, Wild Chrysanthemum Flower, Corydalis, Peppermint, Baikal Skullcap, Lithospermum, Kudingcha, Smartweed, and Licorice to the extracts drawn from plants.Principal Use: It is used for the therapy of dermatitis, particularly of atopic dermatitis.

A radiation irradiation device is provided that includes: a metal target that emits bremsstrahlung X-rays as a radiation beam due to irradiation with an electron beam; a radiation shielding member that includes a slit-shaped radiation passage portion and that is disposed downstream of the metal target in the radiation beam emission direction and is disposed such that a portion of the radiation beam passes through the radiation passage portion and the radiation beam incident to regions other than the radiation passage portion is blocked; and an electron beam generating device that irradiates, onto the metal target, an electron beam such that a diameter at a generation point of the emitted radiation beam is smaller than a length of an entry portion of the radiation passage portion along a length direction of the entry portion.

The invention relates a pharmaceutical composition containing botulinum toxin and a mucopolysaccharide uses thereof with increased pharmacological activity and long lasting botulinum toxin effect.

TECHNICAL FIELD: Lotion for therapy of dermatitisTECHNICAL PROBLEM: To provide a lotion for therapy effective against atopic dermatitis.MEANS FOR SOLVING: It has a composition: Lightyellow Sophora Root, 3%; Turmeric, 2%; Magnolia Bark, 2%; Moutan Bark, 2%; Isatis Leaf, 1%; Borneo Camphor Tree (Dryobalanops aromatica Gaertn.f.), 1%; Amur Cork Tree, 2%; Angelicae Dahuricae Root, 1%; Lemon, 3%; Smartweed, 2%; Licorice, 0.5%; Cnidii Rhizoma, 0.5%; Japanese Angelica Root, 0.5%; salicylic acid, 0.5%; resorcinol, 0.5%; alcohol, 30%; and water, 48.5%.A significant therapeutic effect against atopic dermatitis is obtained by a synergistic effect between antibacterial, antiviral, antiallergic, antiphlogistic, and blood-circulation accelerating actions as pharmacological effects of Lightyellow Sophora Root, Turmeric, Magnolia Bark, Moutan Bark, Isatis Leaf, Borneo Camphor Tree (Dryobalanops aromatica Gaertn.f.), Amur Cork Tree, Angelicae Dahurikae Root, Lemon, Smartweed, and Licorice, accelerating action for skin permeation and antifungal-sterilizing action of Cnidii Rhizoma and Japanese Angelicae Root, accelerating action for keratinization and antifungal-sterilizing action of salicylic acid and resorcinol, as described above.Principal Use: It is used for the therapy of dermatitis, particularly of atopic dermatitis.